Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Arthur J. Gallagher & Co. Stock Climbs 5.5%, Outperforms Peers

Arthur J. Gallagher & Co. Stock Climbs 5.5%, Outperforms Peers

Dow JonesDow Jones2026/10/15 20:34

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Arthur J. Gallagher & Co. rallied 5.5% to $250.10 on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.3% to 7,744.06 and the Dow Jones Industrial Average rising 1.1% to 52,177.69.

This was the stock's second consecutive day of gains.

Arthur J. Gallagher & Co. closed 17.9% below its 52-week high of $304.57, which the company achieved on October 15th.

The stock outperformed some of its peers, as Marsh rose 4.6% to $186.54, MetLife Inc. rose 0.6% to $100.27, and AFLAC Inc. fell 0.14% to $118.05.

Trading volume totaled 2.2 million, compared to the 50-day average of 1.4 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 15, 2026 16:34 ET (20:34 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

No scientific evidence but viral on social media: “Bodybuilding miracle drug” peptide products deregulation file sent to the White House for review, Hims&Hers (HIMS.US) surged 6% in one day.

The temporary admission policy for peptides has been submitted to the White House for review, and compounding pharmacies are expected to receive approval to produce BPC-157 and other substances; HIMS closed up 6% on Thursday.

智通财经•2026/10/16 00:11